Immediate Impact
1 standout
Citing Papers
Precision Medicine: Disease Subtyping and Tailored Treatment
2023 Standout
Works of Suki Subbiah being referenced
Phase 1/2 study of cirmtuzumab and ibrutinib in mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL).
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Suki Subbiah | 21 | 20 | 28 | 12 | 44 | |
| Anna Alperovich | 16 | 26 | 18 | 9 | 41 | |
| Emily C. Ayers | 12 | 25 | 30 | 16 | 58 | |
| Mark Freedman | 9 | 18 | 18 | 11 | 48 | |
| Kenta Nakama | 20 | 20 | 31 | 12 | 70 | |
| Valentina Bonuomo | 8 | 13 | 22 | 7 | 48 | |
| Lanie E. Happ | 9 | 17 | 18 | 9 | 40 | |
| Nicolas Daguindau | 11 | 12 | 14 | 14 | 38 | |
| O Mioduszewska | 20 | 31 | 20 | 13 | 66 | |
| Emily Sheldon‐Waniga | 22 | 14 | 44 | 11 | 72 | |
| Donghong Cai | 8 | 19 | 23 | 13 | 54 |
All Works
Login with ORCID to disown or claim papers
Loading papers...